One well-characterised posttranscriptional regulator is the HuR protein, a member of embryonic lethal abnormal vision Drosophila-like family (ELAV) of RBPs, consisting of Hel-N1/HuB, HuC, HuD, and HuR proteins, initially identified as specific tumour antigens in patients with paraneoplastic neurological phenomena [4, 5]. The gene discussed is ELAVL2; the disease is neoplasm.